Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.20
-0.13-5.58%
Pre-Market: Mar 5, 9:26 AM EDT
Comments
Loading...
Adlai Nortye (ANL) Forecast
NewsEarningsAdlai Nortye (ANL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Adlai Nortye Stock Price, Quotes and Forecasts | NASDAQ:ANL | Benzinga
Explore Adlai Nortye stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ANL.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Adlai Nortye (ANL) stock?
You can purchase shares of Adlai Nortye (NASDAQ:ANL) through any online brokerage.
Who are Adlai Nortye (ANL) competitors?
Other companies in Adlai Nortye’s space includes: Zura Bio (NASDAQ:ZURA), Cabaletta Bio (NASDAQ:CABA), Atossa Therapeutics (NASDAQ:ATOS), Whitehawk Therapeutics (NASDAQ:WHWK) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the forecast, or price target, for Adlai Nortye (ANL) stock?
Adlai Nortye has a consensus price target of $9.00.
What is the current price for Adlai Nortye (ANL)?
The stock price for Adlai Nortye (NASDAQ: ANL) is $2.2 last updated March 5, 2025 at 9:26 AM EST.
Does Adlai Nortye (ANL) pay a dividend?
There are no upcoming dividends for Adlai Nortye.
When is Adlai Nortye (NASDAQ:ANL) reporting earnings?
Adlai Nortye’s FY earnings are confirmed for Tuesday, April 8, 2025.
Is Adlai Nortye (ANL) going to split?
There is no upcoming split for Adlai Nortye.
What sector and industry does Adlai Nortye (ANL) operate in?
Adlai Nortye is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.